Is Target (TGT) Quietly Repositioning Its Brand Around Beauty And Wellness Experiments?

• In August 2026, Target reported stronger quarterly results, raised its full-year 2026 outlook, and expanded its assortment with launches like Target Beauty Studio, hydration brand k2o, performance supplement company Momentous, and INABA Foods USA’s Churu Complete 3oz pet food cans in select stores.
• These moves point to Target doubling down on higher-margin beauty and wellness, exclusive partnerships, and experiential in-store offerings to refresh its brand and broaden its appeal.
• Next, we’ll examine how the upgraded earnings outlook and Beauty Studio launch affect Target’s existing investment narrative and risk balance.

We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Target Investment Narrative Recap

To own Target today, you have to believe it can turn recent operational momentum into durable earnings while rebuilding trust with shoppers and shareholders. The upgraded 2026 outlook and Beauty Studio launch support the near term earnings catalyst, but they do not remove the key risk around brand perception and governance after recent controversies and board-level pushback.

The most relevant update here is Target’s higher full year 2026 earnings guidance, including expected net sales growth around 5% and an operating margin near 6%. Against that backdrop, Beauty Studio and new wellness partnerships like k2o and Momentous look less like isolated launches and more like part of a broader effort to lean into higher margin, differentiated categories that could matter for how sustainable that guidance proves to be.

Yet beneath the stronger guidance, investors should still be aware of mounting concerns around leadership credibility and brand missteps that could...

Read the full narrative on Target (it's free!)

Target’s narrative projects $116.1 billion revenue and $4.2 billion earnings by 2029. This requires 3.0% yearly revenue growth and about a $0.7 billion earnings increase from $3.5 billion today.

Uncover how Target's forecasts yield a $133.84 fair value, a 17% downside to its current price.

Exploring Other Perspectives

Some of the lowest estimate analysts are far more cautious than consensus, assuming revenue of about US$113.4 billion and earnings near US$3.0 billion by 2029, so if you own or are considering Target you may want to compare that pessimistic view on long term margin pressure and capital intensity with the newer beauty and wellness launches to see how your expectations line up with such a different earnings path.

Explore 11 other fair value estimates on Target - why the stock might be worth as much as 37% more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Target research is our analysis highlighting 4 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Target research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Target's overall financial health at a glance.

Seeking Other Investments?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

• AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.
• Find 45 companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com